FDA Inspection
BioGenetics CorporationBioGenetics Corporation – FDA Inspection, Feb 18, 2010
Record Details
This FDA Inspection record concerns BioGenetics Corporation, with an inspection on February 18, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- BioGenetics Corporation
- Inspection Date
- February 18, 2010
- Product Type
- Biologics
View Company Profile
ID · 12a3dca9-3026-45b8-b268-a87058b92b83
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 649602
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of BioGenetics Corporation
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 5, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 12, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 10, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 19, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for BioGenetics Corporation
- FDA Inspection 1266180 - 2025-03-14
- FDA Inspection 1218002 - 2023-09-05
- FDA Inspection 1111175 - 2019-11-12
- FDA Inspection 1058721 - 2018-07-10
- FDA Inspection 985822 - 2016-08-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.